TrialNature communications2024

Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial.

Risa M Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.